Related references
Note: Only part of the references are listed.Monoclonal antibodies in treatment of multiple sclerosis
P. S. Rommer et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Requirement for safety monitoring for approved multiple sclerosis therapies: an overview
P. S. Rommer et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
A Retrospective study of complications of therapeutic plasma exchange in myasthenia
Jeffrey T. Guptill et al.
MUSCLE & NERVE (2013)
A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis
James F. Howard et al.
MUSCLE & NERVE (2013)
Complete stable remission and autoantibody specificity in myasthenia gravis
Fulvio Baggi et al.
NEUROLOGY (2013)
Further developments with antisense treatment for myasthenia gravis
Jon Sussman et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS II (2012)
Functional defect in regulatory T cells in myasthenia gravis
Muthusamy Thiruppathi et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS I (2012)
Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?
Alejandro M. Gomez et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS I (2012)
The role of B cell-activating factor in autoimmune myasthenia gravis
Robert P. Lisak et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS I (2012)
Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative Myasthenia Gravis
Bin Zhang et al.
ARCHIVES OF NEUROLOGY (2012)
Progressive Multifocal Leukoencephalopathy Associated With Immunosuppressive Therapy in Rheumatic Diseases
Eamonn S. Molloy et al.
ARTHRITIS AND RHEUMATISM (2012)
Early effect of tacrolimus in improving excitation-contraction coupling in myasthenia gravis
Tomihiro Imai et al.
CLINICAL NEUROPHYSIOLOGY (2012)
Multidisciplinary treatment of malignant thymoma
Lorenzo Spaggiari et al.
CURRENT OPINION IN ONCOLOGY (2012)
Progressive multifocal leukoencephalopathy in autoimmune diseases
Elisabeth Palazzo et al.
JOINT BONE SPINE (2012)
Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine
Konstantinos Poulas et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis
Fredrik Romi et al.
JOURNAL OF NEUROLOGY (2012)
Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis
Alexandra Pevzner et al.
JOURNAL OF NEUROLOGY (2012)
Characteristics of late-onset myasthenia gravis
Sasa A. Zivkovic et al.
JOURNAL OF NEUROLOGY (2012)
Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature
S. Jarius et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Rituximab in refractory and non-refractory myasthenia: A retrospective multicenter study
Nicolas Collongues et al.
MUSCLE & NERVE (2012)
MYASTHENIA GRAVIS: SLEEP QUALITY, QUALITY OF LIFE, AND DISEASE SEVERITY
Elena Hernandez Martinez De Lapiscina et al.
MUSCLE & NERVE (2012)
Granulocyte macrophage colony-stimulating factor treatment of a patient in myasthenic crisis: Effects on regulatory T cells
Julie Rowin et al.
MUSCLE & NERVE (2012)
Long-lasting treatment effect of rituximab in MuSK myasthenia
J. Diaz-Manera et al.
NEUROLOGY (2012)
Myasthenia gravis and neuromyelitis optica spectrum disorder A multicenter study of 16 patients
M. I. Leite et al.
NEUROLOGY (2012)
Incidence and risk factors for Progressive Multifocal Leukoencephalopathy among patients with selected rheumatic diseases
A. Bharat et al.
ARTHRITIS CARE & RESEARCH (2012)
Thymoma and thymic carcinoma
Federico Venuta et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2012)
A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis
Jeannine M. Heckmann et al.
BMC NEUROLOGY (2011)
PML and rheumatology: The contribution of disease and drugs
E. S. MOLLOY
CLEVELAND CLINIC JOURNAL OF MEDICINE (2011)
Treatment of Myasthenia Gravis Focus on Pyridostigmine
Lorenzo Maggi et al.
CLINICAL DRUG INVESTIGATION (2011)
A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis
Wolfgang Koehler et al.
JOURNAL OF CLINICAL APHERESIS (2011)
The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome
Paul Maddison et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis
Hiroaki Yoshikawa et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Five-year follow-up with low-dose tacrolimus in patients with myasthenia gravis
Naoya Minami et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
ANTI-MuSK ANTIBODY MYASTHENIA GRAVIS: CLINICAL FINDINGS AND RESPONSE TO TREATMENT IN TWO LARGE COHORTS
Jeffrey T. Guptill et al.
MUSCLE & NERVE (2011)
Change in Myasthenia Gravis Epidemiology in Trento, Italy, after Twenty Years
Fabrizio Pallaver et al.
NEUROEPIDEMIOLOGY (2011)
Anti-MuSK autoantibodies block binding of collagen Q to MuSK
Y. Kawakami et al.
NEUROLOGY (2011)
Comparison of IVIg and PLEX in patients with myasthenia gravis
D. Barth et al.
NEUROLOGY (2011)
INCREASING INCIDENCE OF MYASTHENIA GRAVIS AMONG ELDERLY IN BRITISH COLUMBIA, CANADA
Zahra Pakzad et al.
NEUROLOGY (2011)
Rituximab for severe myasthenia gravis - experience from five patients
C. Lindberg et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Comparison of open and minimally invasive thymectomies at a single institution
Samuel J. Youssef et al.
AMERICAN JOURNAL OF SURGERY (2010)
Comparative Analysis of Therapeutic Options Used for Myasthenia Gravis
Aditya Mandawat et al.
ANNALS OF NEUROLOGY (2010)
Antibody effector mechanisms in myasthenia gravis-Pathogenesis at the neuromuscular junction
Alejandro M. Gomez et al.
AUTOIMMUNITY (2010)
Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: Results of a prospective multicenter open-label trial
Joern Peter Sieb et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2010)
To build a synapse: signaling pathways in neuromuscular junction assembly
Haitao Wu et al.
DEVELOPMENT (2010)
Thymectomy for non-thymomatous myasthenia gravis: a comparison of surgical methods and analysis of prognostic factors
Mong-Wei Lin et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2010)
Two-Year Treatment with Cyclosporine Microemulsion for Responder Myasthenia Gravis Patients
Yuriko Nagane et al.
EUROPEAN NEUROLOGY (2010)
MYCOPHENOLATE MOFETIL IN AChR-ANTIBODY-POSITIVE MYASTHENIA GRAVIS: OUTCOMES IN 102 PATIENTS
Michael K. Hehir et al.
MUSCLE & NERVE (2010)
RITUXIMAB IN THE MANAGEMENT OF REFRACTORY MYASTHENIA GRAVIS
Nazlee Zebardast et al.
MUSCLE & NERVE (2010)
CLINICAL FINDINGS IN MuSK-ANTIBODY POSITIVE MYASTHENIA GRAVIS: A US EXPERIENCE
Mamatha Pasnoor et al.
MUSCLE & NERVE (2010)
Autoimmune Targets of Heart and Skeletal Muscles in Myasthenia Gravis
Shigeaki Suzuki et al.
ARCHIVES OF NEUROLOGY (2009)
Rituximab for myasthenia gravis Three case reports and review of the literature
Karl Stiegibauer et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
MYASTHENIA GRAVIS ASSOCIATED WITH ETANERCEPT THERAPY
Dominic B. Fee et al.
MUSCLE & NERVE (2009)
Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction
Rebecca N. Cole et al.
ANNALS OF NEUROLOGY (2008)
Antisense treatment for myasthenia gravis - Experience with Monarsen
Jon D. Sussman et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
Response to therapy in myasthenia gravis with anti-MuSK antibodies
Amelia Evoli et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
Thymectomy for nonthymomatous myasthenia gravis - A critical analysis
Joshua R. Sonett et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone
John Newsom-Davis et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
A potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis
Samia Ragheb et al.
ARCHIVES OF NEUROLOGY (2008)
IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis
Maria Isabel Leite et al.
BRAIN (2008)
Long-term treatment of refractory myasthenia gravis with immunoadsorption
S. Wagner et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2008)
Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead fo IgG1
E. H. Niks et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Improvement with rituximab in a patient with both rheumatoid arthritis and myasthenia gravis
Samar Kerkeni et al.
MUSCLE & NERVE (2008)
A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis
NEUROLOGY (2008)
An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis
D. B. Sanders et al.
NEUROLOGY (2008)
Severe neonatal myasthenia due to maternal anti-MuSK antibodies
Anthony Behin et al.
NEUROMUSCULAR DISORDERS (2008)
Myasthenic crisis: Guidelines for prevention and treatment
Agnes Jani-Aesadi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis:: a non-randomized, non-controlled study
José M. Ponseti et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis
F. Deymeer et al.
NEUROLOGY (2007)
High-dose intravenous immunoglobulin for the treatment of MUSK antibody-positive seronegative myasthenia gravis
Hirokatsu Takahashi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
MRI and clinical studies of facial and bulbar muscle involvement in MUSK antibody-associated myasthenia gravis
Maria Elena Farrugia et al.
BRAIN (2006)
Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy
I Kister et al.
ARCHIVES OF NEUROLOGY (2006)
Increase in incidence of elderly-onset patients with myasthenia gravis in Nagano Prefecture, Japan
M Matsuda et al.
INTERNAL MEDICINE (2005)
Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG
MI Leite et al.
ANNALS OF NEUROLOGY (2005)
Thymus changes in anti-MuSK-positive and -negative myasthenia gravis
L Lauriola et al.
NEUROLOGY (2005)
Etanercept treatment in corticosteroid-dependent myasthenia gravis
J Rowin et al.
NEUROLOGY (2004)
Treatment of refractory myasthenia: Rebooting with high-dose cyclophosphamide
DB Drachman et al.
ANNALS OF NEUROLOGY (2003)
Tacrolimus (FK506) in the treatment of steroid-resistant myasthenia gravis
JM Ponseti et al.
MEDICINA CLINICA (2002)
Successful treatment of myasthenia gravis with tacrolimus
A Evoli et al.
MUSCLE & NERVE (2002)
Treatment of experimental autoimmune myasthenia gravis with recombinant human tumor necrosis factor receptor Fc protein
P Christadoss et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Rituximab: clinical development and future directions
BD Cheson
EXPERT OPINION ON BIOLOGICAL THERAPY (2002)
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
W Hoch et al.
NATURE MEDICINE (2001)
Share Paper
